Sygnature Discovery is Drug Discovery in United Kingdom that focus on protein crystallography business. Founded in 2004. They cover business area such as Provider, outsource drug discovery service, biotech, pharma, company, research facility, validation, identification, lead, optimisation project, capability, medicinal chemistry, bioscience, computational chemistry, dmpk, protein crystallography, accelerate drug discovery project, pre-clinical candidate.
2004
( 20 years old in 2024 )
Protein Crystallography
-
BioCity
Pennyfoot Street
Nottingham NG1 1GR
England, United Kingdom
Private
Provideroutsource drug discovery servicebiotechpharmacompanyresearch facilityvalidationidentificationleadoptimisation projectcapabilitymedicinal chemistrybiosciencecomputational chemistrydmpkprotein crystallographyaccelerate drug discovery projectpre-clinical candidate
* We use standard office opening hours in near Sygnature Discovery's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Sygnature Discovery is Drug Discovery business from United Kingdom that founded in 2004 (20 years old in 2024), Sygnature Discovery business is focusing on Protein Crystallography.
Sygnature Discovery headquarter office and corporate office address is located in BioCity Pennyfoot Street Nottingham NG1 1GR England, United Kingdom.
Sygnature Discovery was founded in United Kingdom.
In 2024, Sygnature Discovery is currently focus on protein crystallography sector.
Above is snippet of Google Trends for "protein crystallography" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Sygnature Discovery, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
